We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$355M
AUM Growth
-$58.3M
(-14%)
Cap. Flow
-$49.6M
Cap. Flow
% of AUM
-13.96%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$5.54M |
| 2 |
iShares MSCI Global Metals & Mining Producers ETF
PICK
|
+$4.8M |
| 3 |
Visa
V
|
+$4.5M |
| 4 |
Zoetis
ZTS
|
+$2.31M |
| 5 |
Wells Fargo
WFC
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$24.9M |
| 2 |
Ferrari
RACE
|
+$19.1M |
| 3 |
CNH
CNH Industrial
CNH
|
+$12.3M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$8.23M |
| 5 |
UBS Group
UBS
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.09% |
| 2 | Technology | 16.07% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 9.16% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Constellation Brands
STZ
$21B
| $37.5K | 0.01% |
163
| – | – |
|
602
Pliant Therapeutics
PLRX
$66.3M
| $37.1K | 0.01% |
5,290
+2,319
| +78% | +$23.7K |
|
|
CAJ
603
DELISTED
Canon, Inc.
CAJ
| $36.5K | 0.01% |
1,503
+146
| +11% | +$3.5K |
|
|
BPMC
604
DELISTED
Blueprint Medicines
BPMC
| $36.2K | 0.01% |
567
+178
| +46% | +$12.8K |
|
605
Hydrofarm Holdings
HYFM
$4.43M
| $35.6K | 0.01% |
235
-35
| -13% | -$6.53K |
|
606
Bumble
BMBL
$396M
| $35.6K | 0.01% |
1,227
-166
| -12% | -$4.59K |
|
607
argenx
ARGX
$61.6B
| $35K | 0.01% |
111
-31
| -22% | -$9.01K |
|
|
NGM
608
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $34.9K | 0.01% |
2,289
+184
| +9% | +$2.87K |
|
609
Dell
DELL
$358B
| $34.9K | 0.01% |
695
| – | – |
|
610
Center Bancorp
CNOB
$1.59B
| $34.6K | 0.01% |
1,082
-103
| -9% | -$3.44K |
|
611
PUT
Macy's
M
$5.7B
| $34.2K | 0.01% |
+400
| New | +$10.3K |
|
612
QuidelOrtho
QDEL
$739M
| $33.6K | 0.01% |
299
+293
| +4,883% | +$31.2K |
|
613
LKQ Corp
LKQ
$5.82B
| $33.3K | 0.01% |
734
+34
| +5% | +$1.74K |
|
614
MGM Resorts International
MGM
$9.66B
| $33K | 0.01% |
788
| – | – |
|
615
ProShares Ultra S&P500
SSO
$8.68B
| $32.8K | 0.01% |
1,000
-4,080
| -80% | -$131K |
|
616
Tandem Diabetes Care
TNDM
$1.22B
| $32.6K | 0.01% |
+280
| New | +$32.7K |
|
617
Workhorse Group
WKHS
$33.1M
| $32.5K | 0.01% |
+2
| New | +$22K |
|
|
VRN
618
DELISTED
Veren
VRN
| $32.4K | 0.01% |
4,482
| – | – |
|
619
Perrigo
PRGO
$1.88B
| $32.4K | 0.01% |
+842
| New | +$32.1K |
|
620
Axos Financial
AX
$5.25B
| $31.8K | 0.01% |
+686
| New | +$36.2K |
|
621
Nuveen Quality Municipal Income Fund
NAD
$2.5B
| $31.6K | 0.01% |
2,368
-3,169
| -57% | -$45.5K |
|
|
CMBT
622
CMB.TECH NV
CMBT
$5.7B
| $31.4K | 0.01% |
2,933
| – | – |
|
|
MPT
623
Medical Properties Trust
MPT
$2.02B
| $31.3K | 0.01% |
1,481
-267
| -15% | -$5.75K |
|
624
BorgWarner
BWA
$12.7B
| $30.9K | 0.01% |
903
-44
| -5% | -$1.64K |
|
625
Cogent Communications
CCOI
$444M
| $30.9K | 0.01% |
466
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2022 Portfolio in Review
As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.
- Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
- Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
- Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
- Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
- Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
- Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
- Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.
Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.